Acotec Scientific Holdings Limited
6669.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.79B
Close$
Share Statistics
| Market cap | $1.79 Billion |
|---|---|
| Enterprise Value | $1.90 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.39 |
| Beta | -0.03 |
| Outstanding Shares | 299,381,481 |
Return
| Return on Equity | -3.60% |
|---|---|
| Return on Assets | -2.82% |
| Return on Invested Capital | -3.23% |
Valuation & Multiples
| P/E Ratio | -31.91 |
|---|---|
| PEG | 16.68 |
| Price to Sales | 2.89 |
| Price to Book Ratio | 1.45 |
| Enterprise Value to Revenue | 3.05 |
| Enterprise Value to EBIT | -38.34 |
| Enterprise Value to Net Income | -38 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$191.48 M
Average shareholder expectationNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Acotec Scientific Holdings Limited
955 employees
CEO: Jing Li Acotec Scientific Holdings Limited is a medical technology firm specializing in the research and development of percutaneous transluminal angioplasty (PTA) and drug-coated balloon devices. These innovative products are designed to addres...